Alice Ballerie
Overview
Explore the profile of Alice Ballerie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
355
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Couturaud F, Schmidt J, Sanchez O, Ballerie A, Sevestre M, Meneveau N, et al.
Lancet
. 2025 Mar;
405(10480):725-735.
PMID: 40023651
Background: In patients with venous thromboembolism at high risk of recurrence for whom extended treatment with direct oral anticoagulants has been indicated, the optimal dose is unknown. We aimed to...
2.
Le Tallec E, Bellamri N, Lelong M, Morzadec C, Frenger Q, Ballerie A, et al.
Front Immunol
. 2024 Oct;
15:1468821.
PMID: 39464886
Introduction: Systemic sclerosis (SSc) is an autoimmune disease characterized by antinuclear antibody production, which has been linked to an excess of apoptotic cells, normally eliminated by macrophages through efferocytosis. Additionally,...
3.
Gouin-Thibault I, Mansour A, Caribotti C, Pierre-Jean M, Bouzille G, Ballerie A, et al.
J Thromb Haemost
. 2024 Jul;
22(10):2864-2872.
PMID: 39019439
Background: Tinzaparin could be easier to manage than unfractionated heparin in patients with severe renal impairment. However, clinical and pharmacologic data regarding its use in such patients are lacking. Objectives:...
4.
Lescoat A, Cavalin C, Ehrlich R, Cazalets C, Ballerie A, Belhomme N, et al.
Lancet Rheumatol
. 2024 Jan;
1(4):e257-e264.
PMID: 38229382
Systemic sclerosis is a rare connective tissue disease characterised by a wide range of clinical manifestations. Compared with previous sets of criteria, the 2013 American College of Rheumatology and European...
5.
Leven C, Menard P, Gouin-Thibault I, Ballerie A, Lacut K, Ollier E, et al.
Pharmaceutics
. 2023 Feb;
15(2).
PMID: 36839986
Apixaban and rivaroxaban have first-line use for many patients needing anticoagulation for venous thromboembolism (VTE). The pharmacokinetics of these drugs in non-obese subjects have been extensively studied, and, while changes...
6.
Cavalin C, Lescoat A, Sigaux J, Macchi O, Ballerie A, Catinon M, et al.
Rheumatology (Oxford)
. 2022 Dec;
62(8):2707-2715.
PMID: 36458909
Objectives: Develop and validate a thorough exposure questionnaire to comprehensively explore crystalline silica (SiO2) exposure in the general population (gender-specific, occupational and non-occupational) and in patients with autoimmune diseases (rheumatoid...
7.
Ballerie A, Nguyen Van R, Lacut K, Galinat H, Rousseau C, Pontis A, et al.
Thromb Res
. 2021 Oct;
208:39-44.
PMID: 34689080
Background: Direct oral anticoagulants (DOAC) use remains challenging in obese patients treated for Venous-Thrombo-Embolism (VTE) due to the paucity of prospective and dedicated studies. Objective: To assess rivaroxaban and apixaban...
8.
Coirier V, Chabanne C, Jouneau S, Belhomme N, Ballerie A, Cazalets C, et al.
Diagnostics (Basel)
. 2021 Oct;
11(10).
PMID: 34679436
Background: to compare three existing screening algorithms of pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc) with the results of a multidisciplinary team (MDT) meeting from a tertiary center. Methods:...
9.
Doumeizel P, Robin F, Ballerie A, Moreau B, Le Bot A, Polard E, et al.
Rev Prat
. 2021 Sep;
71(6):587-596.
PMID: 34553543
Side effects of long-term oral corticosteroid therapy. Systemic corticosteroid therapy has been used for over 70 years, and is still the cornerstone of the treatment of many conditions, in particular...
10.
Lescoat A, Robin F, Belhomme N, Ballerie A, de Saint Riquier M, Sebillot M, et al.
Arthritis Care Res (Hoboken)
. 2021 Sep;
75(2):299-306.
PMID: 34477332
Objective: To define a semiquantitative classification of finger pulp blood flow (FPBF) and to evaluate whether this classification could be used to assess FPBF in healthy controls and in systemic...